Drug management of patient with heart failure after cardiac pacing by Yazan Dwayat
DRUG MANAGEMENT OF PATIENT WITH 
HEART FAILURE AFTER  
CARDIAC PACING 
 
 Speaker: Student of 5th course Yazan Dwayat 
Scientific advisers: ass. prof. Zhuravka N.V.  
                              ass. prof. Kanishcheva O.V. 
                              prof. Yabluchanskyi M.I. 
  Heart Failure (HF) is a clinical syndrome characterized by 
typical symptoms (e.g. breathlessness, ankle swelling and 
fatigue) that may be accompanied by signs (e.g. elevated 
jugular venous pressure, pulmonary crackles and peripheral 
oedema) caused by a structural and/or functional cardiac 
abnormality, resulting in a reduced cardiac output and/or 
elevated intracardiac pressures at rest or during stress. 
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  Treatment of HF includes interventions in lifestyle, drug 
therapy, cardiac resynchronization therapy (CRT), as well as 
cardiac surgery, with priority being given to the first two. 
 Pacemakers are well-established therapies of severe 
bradyarrhythmias, and one of them is complete AV block. 
 In patients with AV block and HF placing an electrode in the 
intraventricular septum can lead to CRT effect achievement.  
 
 To overview management of the patient with heart failure 
and cardiac pacemaker, implanted due to AV block of III 
degree on the example of clinical case. 
 Name: B.S.N. 
 Gender: female. 
 Age: 78 years old. 
 Occupation: retired. 
 Admitted to the hospital #5 on 26th of September 2017. 
 Oedema of the shins. 
 Cough and dyspnea at minimal exertion, absent at rest. 
 Arterial hypertension more than 10 years (max 200/100 mm 
Hg, adapted to 130-140/80 mm Hg) Patient took enalapril + 
hydrochlorothiazide 10mg/12.5 mg once a day. 
 2011 - myocardial infarction. The AV block of IIId degree 
with Adams-Stokes Syndrome was diagnosed but patient 
refused the cardiac pacemaker implantation.  
 According to the patient, she took “a bunch of pills” every 
day, which she cannot remember the name of (the record is 
not available). 
 
  2014 - second myocardial infarction (the record is not 
available).  
 Summer 2017 – worsening of the disease, with complaints 
of dry cough and shortness of breath, worsened by exertion, 
legs oedema, frequent fainting. 
 
Conclusion: 
AV block of 3d 
degree with VR 27 
bpm, AR 85 bpm. 
QRS  114 msec 
QT     572 msec 
 No signs of focal 
myocardial lesion.  
 23.08.17 the cardiac pacemaker was implanted, in the DDDR 
pacing mode, pacing threshold: 1st electrode – 0.5 V, 2nd – 0.6 V. 
The first electrode was set in the interventricular septum, the 
second – in the anterolateral wall of the right atrium. 
 DDDR is a dual-chamber pacemaker means the pacemaker is 
pacing electric activity in the atrium and the ventricle and it is 
sensing activity in each of them. 
 After implantation of cardiac pacemaker the symptoms were not 
completely controlled, and patient was hospitalized to the 
cardiology department to correct the treatment. 
 
 Denies malaria, tuberculosis, diabetes mellitus, 
dermatovenerologic diseases. 
 1956 - Hepatitis A. 
 Patient has no allergies and no reactions to drugs and 
medication. 
 Denies smoking, alcohol intake and drug addiction. 
 Family history is significant for cardiovascular diseases. 
 Meningioma of the left parietal region. 
 Temperature             36,7oC 
 PS                             78 bpm (both hands) 
 BP                             130/80 mm Hg (both hands) 
 Respiratory rate        18 pm 
 Height                       166 cm 
 Weight                       82 kg 
 BMI                           29 kg/m2 
 
 General condition: 
   Her mood, orientation in space, posture and development are 
normal. 
 Skin and mucous membranes:  
   Skin, subcutaneous fat tissue, nails, mucous membranes, 
tongue are normal. 
 Musculoskeletal system examination unremarkable. 
 Peripheral lymph nodes are not palpable.  
 The thyroid is not palpable. 
 Oedema of lower third of both shins. 
 Respiratory System:  
• pulmonary percussion –normal  
• auscultation - weakened vesicular breathing, no 
adventitious sounds 
 Cardiovascular system:  
• heart borders extended to the left on 1,5 cm of mid 
clavicular line, HR =78 bpm, regular. 
• no pulse deficiency, heart sounds are muted, accent of the II 
tone above the aorta. 
   Gastrointestinal system:  
• abdomen is soft, painless, symmetrical, no discrepancies 
of the abdominal muscles, no visible peristalsis;  
• liver edge is smooth, painless, palpated at the costal arch, 
spleen and pancreas are not palpable; 
• stool is normal. 
 Urinary system:  
• kidneys are not palpable. Pasternatsky’s sign negative on 
both sides. Urination is normal. 
Prescribed Recommended 
 CBC  
 Urinalysis  
 FPG (fasting plasma glucose) 
 Liver function tests (LFT) 
 Renal function tests (RFT) 
 Lipid profile 
 EchoCG 
 ECG (12-lead) 
 Chest X-ray  
 
 Serum electrolyte levels 
 B-type natriuretic peptide (BNP) 
 N-terminal pro-B-type (NT-
proBNP) 
 Doppler flow ultrasonographic 
study 
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Parameters Result Normal range 
Hemoglobin 151 F 120 - 140 g/ l  
Erythrocytes  5,29 F 3,9-4,7 T/ l 
Hematocrit 45,0 35 – 47 5% 
Leukocytes 6,2 4,0 – 9,0 g/L 
ESR  4 F 2-15 mm/h 
Stab neutrophils  1,1 1-6 % 
Segmented neutrophils 47 47-72 % 
Eosinophils  2,5 0,5-5,0%  
Basophils 1,9 1-1,0 % 
Lymphocytes  36 19-37%  
Monocytes 8,9 3-11 % 
Platels 261 180-320 g/L 
Conclusion: increase of hemoglobin level, erythrocytosis.   
Parameters Result Normal range 
Specific gravity 1,030 1,001-1,040 
Reaction 6,0 5,0-7,0 
Protein Not detected 0,033 g/ l 
Glucose Absent Absent 
Erythrocytes 0 0-2  
Leucocytes 1-2 6-8  
Сonclusion: all parameters within the normal range. 
Parameters Result Normal range 
Total bilirubin 18, 6 2-20 μmol/l  
AlAt  20,1 8-40 U/L 
AsAt 27,5 8-38 U/L 
Creatinine 81 60-123 μmol/l 
Glucose  5, 8 4,2-6,1 μmol/l 
Сonclusion: all parameters within the normal range. 
Parameters Result Normal range 
Cholesterol 5,41 < 5.2 mmol/l 
VLDL 0.65 < 1.0 mmol/l 
LDL 2.98 < 3.5 mmol/l 
HDL 1.77 > 0.9 mmol/l 
Triglycerides 1.45 ≤ 2.3 mmol/l 
Сonclusion:  hypercholesterolemia, type I. 
INDEX RESULT  NORMAL 
Aorta 31 20-37mm 
Aortic valve 18 17-26mm 
Mitral valve 31 26-35mm 
Left atrium 33.0 To 38 mm 
End Diastolic velocity 100 50-180 cm/s  
End Systolic volume 50.0 35-55mm  
Left Ventricle Wall 13.2  6-11mm  
Ejection Fraction 48 55-78% 
Left Ventricle amplitude 8,8 7-13mm 
Intraventricular septum 12 6-11mm 
Right atrial diameter 41 ≤45mm 
Right Ventricle diameter 24 9-26mm 
Conclusion: atherosclerostic cardiosclerosis, aorta atherosclerosis,  
LV hypertrophy. Dyssynergic areas were not identified. 
Conclusion: 
Pacemaker rhythm, 
bipolar stimulation 
of the ventricles 
HR        89 bpm 
QRS      144 msec 
QT         364 msec 
   Conclusion: no 
pathological changes in the 
lungs. Pacemaker in left 
subcostal area, visible 
electrode in the right heart 
chambers. 
 Atherosclerosis (sclerotic changes of aorta and aortic valve).  
 Arterial hypertension. 
 Condition after the implantation of cardiac pacemaker (23.08.17) 
due to AV-block III degree with Adams-Stokes syndrome.  
 Heart failure. 
 Hypercholesterolemia, type I. 
 Overweight. 
 Ischemic heart disease. Atherosclerotic and post infarction (2011, 
2014) cardiosclerosis. Aorta atherosclerosis.  
 Heart failure with reduced ejection fraction (48%), III FC, stage C. 
 Arterial hypertension, III stage, hypertensive heart (LVH), 3 degree. 
 CVD risk very high. 
 Permanent pacemaker (23.08.17) due to AV-block III degree with 
Adams-Stokes syndrome. 
 Hypercholesterolemia, type I. 
 Overweight. 
 
 Clopidogrel 75 mg once a day 
 Bisoprolol 2,5 mg in the morning 
 Torasemide 2,5 mg in the morning 
 Valsartan 40mg twice a day 
 Rosuvastatin 5 mg in the evening 
 Meldonium 5,0 ml IV № 10 
 Pentoxifylline 5,0 ml + 100,0 ml saline IV infusion № 2 
LIFESTYLE MODIFICATION 
 DASH diet  
 a diet rich in fruits, vegetables, low fat or nonfat dairy 
 includes mostly whole grains, lean meats, fish and poultry, nuts and 
beans 
 Daily aerobic activity 
 25 to 30 minutes  walking at a fast pace 
 
 
 
PHARMACOLOGICAL TREATMENT 
 Torasemide 2,5 mg in the morning (ones in 3 days) 
 Bisoprolol 2,5 mg in the morning 
 Rosuvastatin 5 mg in the evening 
 Valsartan 40mg twice a day 
 Acetylsalicylic acid 75 mg once a day in the evening 
  Patient takes medication regularly 
 Patient's condition is much better: no oedema, no 
cough, exercise tolerance increased. 
ECG before pacing ECG after pacing 

 Precept “festina lente” is important in all medical practice, 
and in interventional cardiology - in the first place. 
 Cardiac pacemaker in the presence of possible solutions to 
the problem of arrhythmias and HF it does not cancel, but 
modifies the medical support of patients. 
 To prolong patient's life, it’s very important to establish a 
timely diagnosis and prescribe appropriate therapy. 

